Big Data Genetics Genome 
BioTech 365
APRIL 16, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientists are on a path to sequencing 1 million human genomes and use big data to unlock genetic secrets.The first draft of the human genome was published … Continue reading →
ACRP blog
JUNE 7, 2023
If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Edited by Gary Cramer The post Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research appeared first on ACRP.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JULY 24, 2024
AI-driven models also help in identifying the most effective treatment regimens based on patient-specific factors, including genetic makeup and treatment history. RELATED: OncoHealth Expands Its Iris Platform for Digital Cancer Care Big Data and AI in Oncology Big data analytics is opening new avenues in cancer research.
XTalks
APRIL 5, 2021
The Human Genome Project could not have succeeded without the use of bioinformatics. Specific skills are required to succeed in this job; these include advanced writing skills for scientific literature, developing software tools, working on genome sequencing projects, and designing DNA sequencing libraries. Bioinformatics Engineer.
Pharma Marketing Network
OCTOBER 14, 2024
The rise of big data analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.
Pharma Marketing Network
OCTOBER 17, 2024
Personalized Medicine and Targeted Campaigns Personalized medicine is revolutionizing the pharmaceutical industry by tailoring treatments to individual genetic profiles and health conditions. This trend is extending to pharma marketing, where companies are increasingly focusing on targeted campaigns that address specific patient subgroups.
Worldwide Clinical Trials
APRIL 7, 2025
Solid tumors exhibit genetic variances between patients with a shared diagnosis and within a single patient, even across one tumor. Furthermore, comprehensive genomic profiling in clinical trials generates real-world data that inform post-approval use and further refine treatment algorithms.
Expert insights. Personalized for you.
40 
Let's personalize your content